|
|
? |
AFRICA: Drug giant to clamp down on diverting of ARVs
[This report does not necessarily reflect the views of the United Nations]
JOHANNESBURG, 23 May (PLUSNEWS) - International drug giant GlaxoSmithKline (GSK) says it is close to implementing measures to stem the illegal diversion of anti-AIDS drugs from developing countries to wealthy nations.
According to London's Financial Times, by the end of this year the company aims to have implemented an anti-fraud identification system that includes new packaging and labelling for its antiretrovirals (ARVs).
Medicines heading for Africa will be coated red and shipped in packaging with easily traceable identity codes, while medication destined for Western markets will remain white in colour.
The measure is expected to enable GSK to identify specific wholesalers in Africa, who have been selling humanitarian drugs, as well as the suppliers profiting from such parallel importing into Europe.
[ENDS]
MORE NEWS BRIEFS
|
|
? |
|
|
|
|
| Links |
Le portail d'informations générales de la Côte d’Ivoire
|
Sida Info Services
|
Le Fonds mondial de lutte contre le SIDA, la tuberculose et le paludisme
|
Le Réseau Afrique 2000
|
The Global Fund to fight AIDS, Tuberculosis & Malaria
|
PlusNews does not take responsibility for info in links supplied. |
|
|
|
|
|
[Back] [Home Page]
Click here to send any feedback,
comments or questions you have about PlusNews Website or if you prefer you can
send an Email to Webmaster
Copyright ? IRIN 2005
The material contained on www.PlusNews.org comes to you via IRIN, a UN humanitarian news and information service, but may not necessarily reflect
the views of the United Nations or its agencies.
All PlusNews material may be reposted or reprinted free-of-charge; refer to the IRIN copyright page for conditions of use. IRIN is a project of the UN
Office for the Coordination of Humanitarian Affairs.
|